Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Xuewei Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0380-9588; OpenAlex author ID A5100777985. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. MSC-derived exosomes co-delivering anti-miR-221 and gemcitabine for inhibiting the proliferation of pancreatic cancer Last author DOI 10.1186/s12967-026-08764-0↗
  2. Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells. Co-author DOI 10.3892/or.2023.8666↗
  3. Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case series and literature review Co-author DOI 10.21203/rs.3.rs-1969267/v1↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bingqing Du · 1 shared paper, 2026 · strength 0.29
  2. Zimei Wu · 1 shared paper, 2024 · strength 0.22
  3. Yan Li · 1 shared paper, 2024 · strength 0.22
  4. Ji He · 1 shared paper, 2024 · strength 0.22
  5. Bingqing Du · 1 shared paper, 2022 · strength 0.15
  6. Huihong Liang · 1 shared paper, 2022 · strength 0.15
  7. Xiaofeng Jiang · 1 shared paper, 2022 · strength 0.15
  8. Xiaodong Song · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.